News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alchemia to Present at Cowen and Company 31st Annual Health Care Conference



3/4/2011 2:47:14 PM

BRISBANE, Australia--(BUSINESS WIRE)--Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update at the Cowen and Company 31st Annual Health Care Conference at 4:45 p.m. EST on Monday, March 7, 2011. The presentation will provide an update on the approval process for the Company’s generic fondaparinux product and the status of the pivotal Phase III study of HA-Irinotecan in metastatic colorectal cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES